CD274 and melanoma: Furthermore, the analysis showed that HLA-DR expression in melanoma cells may be a biomarker for tumors primed with activated T-cells and an appropriate IFNγ response to mediate sensitivity to PD-1/PD-L1 blockade, which is also associated with immune response (Johnson et al., 2016).